Images

Filter by

Risk Score Group
Risk Score Group
Rate of ICD therapies
Rate of ICD therapies
Figure 1 Characteristics of Athletes with Hypertrophic Cardiomyopathy Compared to Sedentary Patients with Hypertrophic Cardiomyopathy that Highlight the Need to Utilize an Array of Clinical Tools Available to the Clinician
Figure 1: Characteristics of Athletes with Hypertrophic Cardiomyopathy Compared to Sedentary Patients with Hypertrophic Cardiomyopathy that Highlight the Need to Utilize an Array of Clinical Tools Available to the Clinician
Figure 1 A Dot Plot Representation of the Relationship between PVC Burden and Ejection Fraction in 174 Patients Referred for PVC Catheter Ablation
Figure 1: A Dot Plot Representation of the Relationship between PVC Burden and Ejection Fraction in 174 Patients Referred for PVC Catheter Ablation
Table 3 Clinical Utility of Cardiovascular Magnetic Resonance Techniques Ordered by Pathophysiological Mechanism and Tissue Characteristics
Table 3: Clinical Utility of Cardiovascular Magnetic Resonance Techniques Ordered by Pathophysiological Mechanism and Tissue Characteristics
Figure 11 Number of Deaths of Patients with Thalassaemia Major in the UK
Figure 11: Number of Deaths of Patients with Thalassaemia Major in the UK
Table 2 T1 Mapping Studies in Heart Failure Populations
Table 2: T1 Mapping Studies in Heart Failure Populations
Table 1 T1 Mapping Studies in All comers for Cardiovascular Magnetic Resonance Extracellular Volume is used as the Parameter for All
Table 1: T1 Mapping Studies in All-comers for Cardiovascular Magnetic Resonance (Extracellular Volume is used as the Parameter for All)
Figure 10 Association between Extracellular Volume and Clinical Outcome per Left Ventricular Ejection Fraction
Figure 10: Association between Extracellular Volume and Clinical Outcome per Left Ventricular Ejection Fraction
Figure 9 Association of Cardiovascular Magnetic Resonance Parameters with All cause Mortality
Figure 9: Association of Cardiovascular Magnetic Resonance Parameters with All-cause Mortality
Figure 8 Multiparametric Cardiovascular Magnetic Resonance Tissue Characterisation
Figure 8: Multiparametric Cardiovascular Magnetic Resonance Tissue Characterisation
Figure 7 Diagnostic Utility of Tissue Characterisation using Native T1 and Extracellular Volume Fraction Based on MOLLI at 1 5T
Figure 7: Diagnostic Utility of Tissue Characterisation using Native T1 and Extracellular Volume Fraction (Based on MOLLI at 1.5T)